Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial

Published:2018-03-26 Issue:5 Volume:48 Page:410-416
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Miyake Osamu¹²,Murata Kyoko¹,Tanaka Shiro³,Ishiguro Hiroshi⁴,Toi Masakazu⁵,Tamura Kazuo⁶,Kawakami Koji¹

Affiliation:

1. Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto

2. Kyowa Hakko Kirin Co., Ltd., Tokyo

3. Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto

4. Department of Clinical Oncology, School of Medicine, International University of Health and Welfare, Tochigi

5. Department of Breast Surgery, Kyoto University Hospital

6. Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

Funder

Kyowa-Hakko Kirin Co., Ltd

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/48/5/410/25536064/hyy030.pdf

Reference29 articles.

1. Febrile neutropenia;Klastersky;Curr Opin Oncol,1993

2. Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients;Chirivella;Breast Cancer Res Treat,2009

3. A retrospective evaluation of chemotherapy dose intensity and supportive care for early-stage breast cancer in a curative setting;Lyman;Breast Cancer Res Treat,2013

4. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices;Lyman;J Clin Oncol,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study;YAKUGAKU ZASSHI;2024-09-01

2. Comparative Cost-Effectiveness of Gemcitabine and Cisplatin in Combination with S-1, Durvalumab, or Pembrolizumab as First-Line Triple Treatment for Advanced Biliary Tract Cancer;Journal of Gastrointestinal Cancer;2024-08-22

3. Remote Patient Monitoring to Transform Management of Febrile Neutropenia in Cancer Patients;NEJM Catalyst;2024-03-20

4. The clinical efficacy of pegfilgrastim to prevent febrile neutropenia in breast cancer patients receiving docetaxel- cyclophosphamide chemotherapy;2024-02-14

5. Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan;The European Journal of Health Economics;2023-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3